Marta Sivitz, MD
NPI 1952301871 · Ophthalmology Physician · Phila, PA
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Marta Sivitz, MD is a Ophthalmology Physician provider in Phila, PA (NPI 1952301871).
Provider details
- NPI number
- 1952301871
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 012098E (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
826 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 360 | $132 |
| Established Patient Problem Focused Exam of Visual System92012 | 167 | $93 |
| Imaging of Optic Nerve92133 | 77 | $38 |
| Imaging of Retina92134 | 61 | $43 |
| Photography of the Retina92250 | 59 | $39 |
| Exam of Visual Field With Extended Testing92083 | 46 | $67 |
| New Patient Complete Exam of Visual System92004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 629 | 167 |
| Brimonidine Tartrate | 173 | 42 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 151 | 35 |
| Timolol Maleate | 145 | 39 |
| Bimatoprostbrand: Lumigan | 66 | 15 |
| Cyclosporinebrand: Restasis | 43 | 12 |
| Prednisolone Acetate | 40 | 26 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$105 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-22
- Last updated
- 2007-08-03
Frequently asked questions
- What is Marta Sivitz's NPI number?
- Marta Sivitz's National Provider Identifier (NPI) is 1952301871, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Marta Sivitz's specialty?
- Marta Sivitz is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is Marta Sivitz located?
- Marta Sivitz's practice location on file with NPPES is 1726 S Broad St, Phila, PA 19145-2300.
- What is Marta Sivitz's phone number?
- The practice phone number listed in the NPPES registry for Marta Sivitz is (215) 463-3400.
- Does Marta Sivitz accept Medicare?
- Marta Sivitz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Marta Sivitz's NPI active?
- Yes — Marta Sivitz's NPI (1952301871) is active in the NPPES registry as of the last update on 2007-08-03.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.